开创性:以护理为主导的方法来缓解帕金森病中便秘
Wenyao Geng1, Mengdie Ren2, Feng Zhao2
1The Central Hospital of China Aerospace Corporation, Beijing, China.
BMC geriatrics
|October 13, 2023
概括
为帕金森病患者的便秘制定了一项新的护理干预计划. 这项科学和可行的计划解决了对PD有效便秘管理的关键需求.
科学领域:
- 神经学 神经学
- 护理科学 护理科学
背景情况:
- 便秘是帕金森病 (PD) 中普遍存在的非运动性症状,通常是运动缺陷之前的症状.
- 在PD中,便秘的不充分管理可能会导致严重的并发症,如结肠卷发症和伪肠道阻塞,并损害药物疗效.
- 在PD患者的便秘方面,基于证据的综合性护理干预措施存在重大差距.
研究的目的:
- 制定一个科学和全面的护理干预计划,用于管理帕金森病患者的便秘.
主要方法:
- 一个跨学科的护理研究小组进行了文献审查,起草了初步干预计划.
- 与15名专家 (神经病学家,护理专家,营养师,康复医生) 进行了两轮的Delphi咨询,以改进指标.
- 专家反主要集中在干预计划的指标的重要性和可行性.
主要成果:
- 专家咨询过程确定了干预计划的三个主要指标,九个次要指标和22个第三级指标.
- 关键指标包括变化阶段 (预意,意向,行动),风险感知,自我有效性和行为组件.
- 完成的指标通过专家共识确认其重要性和可行性.
结论:
- 一个科学验证和可行的护理干预计划,用于帕金森病患者的便秘成功开发.
- 该计划为临床护理实践提供了一个实用的框架,解决了一个关键的未满足需求.
- 该干预计划显示了临床应用和广泛采用在治疗PD相关便秘的重大潜力.
更多相关视频
相关概念视频
Parkinson's Disease: Treatment
283
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
283
Parkinson's Disease: Overview
579
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
579
Drugs for Treatment of Constipation-Predominant IBS
183
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
183
Irritable Bowel Syndrome III: Medical and Nursing Management
217
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
217
Peritoneal Dialysis III: Nursing Management
31
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
31
Drugs Affecting GI Tract Motility: Other Laxatives
244
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
244


